List view / Grid view
17 January 2011 | By Roche
Erich Hunziker, Chief Financial Officer, Chief Information Officer and Deputy Head of the Corporate Executive Committee has decided to retire from Roche at the end of March 2011...
17 January 2011 | By Andrew Lloyd & Associates
Agreement covers metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting Parkinson's disease...
17 January 2011 | By The Scott Partnership
Expansion enables them to handle larger projects from preformulation through to Phase IIa...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Dr Eric Gluck will host a scientific presentation highlighting the benefits of the Thermo Scientific B.R.A.H.M.S procalcitonin (PCT) assay at the Society of Critical Care Medicine (SCCM) 40th Critical Care Conference 2011.
13 January 2011 | By KDM Communications
Scientists at the Center for CIPSM, have taken advantage of the 3D scanning capabilities of the premium Quad4 Monochromators™-based Infinite M1000 microplate reader...
12 January 2011 | By Eli Lilly and Company
Eli Lilly announces that the FDA Gastrointestinal Drugs Advisory Committee has recommended that additional studies be conducted...
11 January 2011 | By The Scott Partnership
Prism Ideas, announced that the company has appointed Carol Hills as chief operations officer (COO) following a successful two-year period as the company's director of medical marketing...
11 January 2011 | By Eli Lilly and Company
Global agreement will lead to joint development of diabetes compounds currently in mid- and late-stage development...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it will showcase its clinical assay for Procalcitonin (PCT), which aids in the risk assessment of critically ill patients with sepsis, at the Society of Critical Care Medicine (SCCM) 40th Critical Care Conference 2011.
7 January 2011 | By Lallemand Pharma Europe
Lallemand Pharma Europe and GlaxoSmithKline announced the launch of ISMIGEN® in Poland...
6 January 2011 | By The Scott Partnership
Novozymes Biopharma is presenting two scientific posters on the manufacturing and use of recombinant albumin in formulation...
6 January 2011 | By College Hill Ltd
Lab21 Limited, today announced that it has acquired Microgen Bioproducts Ltd a UK company specialising in the development, manufacture and sale of diagnostic tests...
6 January 2011 | By College Hill Ltd
Bicycle Therapeutics today announced the appointment of Andy Sandham as non-executive Chairman. Andy brings over 30 years experience in building biotechnology businesses...
5 January 2011 | By The Scott Partnership
Increasing trial complexity and duration of studies, patient non-compliance is a growing issue...
5 January 2011 | By Citigate Dewe Rogerson Ltd
Crescendo Biologics Limited (Crescendo) today announces the appointment of Mike Romanos as Chief Executive Officer...
